Clearside Biomedical Inc.

29/07/2024 | Press release | Distributed by Public on 29/07/2024 20:52

Clearside Biomedical’s Partner Arctic Vision Reports Positive Topline Results from Phase 3 Clinical Trial of ARCATUS® for Suprachoroidal Use in Uveitic Macular Edema Patients[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.